Mattson Financial Services LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,688 shares of the healthcare conglomerate’s stock after selling 70 shares during the period. UnitedHealth Group comprises about 2.0% of Mattson Financial Services LLC’s investment portfolio, making the stock its 8th largest position. Mattson Financial Services LLC’s holdings in UnitedHealth Group were worth $5,664,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 0.6% in the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after purchasing an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in UnitedHealth Group by 0.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after purchasing an additional 94,641 shares during the period. Bank of New York Mellon Corp boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after purchasing an additional 35,533 shares during the period. Dimensional Fund Advisors LP boosted its holdings in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. Finally, Ameriprise Financial Inc. boosted its holdings in shares of UnitedHealth Group by 0.6% during the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after acquiring an additional 21,149 shares during the period. Institutional investors own 87.86% of the company’s stock.
Analysts Set New Price Targets
UNH has been the subject of several analyst reports. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Tuesday, October 1st. Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. TD Cowen boosted their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Argus upped their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, Morgan Stanley upped their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $614.17.
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock opened at $581.56 on Wednesday. The company’s 50-day moving average price is $582.58 and its two-hundred day moving average price is $528.49. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a market cap of $537.02 billion, a PE ratio of 35.55, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.14 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.44%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- How to Start Investing in Real Estate
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Best Aerospace Stocks Investing
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- What is the Dow Jones Industrial Average (DJIA)?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.